查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765280

全球治疗性血浆置换市场

Therapeutic Plasma Exchange
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2030年，全球治疗性血浆置换市场规模将达21亿美元

全球治疗性血浆置换市场规模预计在2024年为15亿美元，到2030年将达到21亿美元，在分析期间（2024-2030年）的复合年增长率为6.2%。神经系统疾病是本报告分析的细分市场之一，预计其复合年增长率为6.9%，到分析期结束时将达到7.896亿美元。肾臟病学细分市场在分析期间的复合年增长率预计为5.3%。

美国市场规模估计为 4.101 亿美元，中国市场预计复合年增长率为 5.7%

美国治疗性血浆置换市场规模预计在2024年达到4.101亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到3.317亿美元，在2024-2030年的分析期间内，复合年增长率为5.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为5.5%和5.1%。在欧洲，预计德国的复合年增长率为4.6%。

全球治疗性血浆置换市场－主要趋势与驱动因素摘要

为什么治疗性血浆置换在现代医疗保健中如此重要？

治疗性血浆置换 (TPE) 已成为治疗各种自体免疫、血液疾病和神经系统疾病的救命良方。此方法包括从患者血液中抽取血浆，并以新鲜血浆或血浆代用品取代，从而帮助清除体内有害的抗体和毒素。 TPE 在Guillain-Barré二氏症候群、重症肌无力、多发性硬化症等疾病的治疗中日益普及，凸显了其在医疗保健领域的重要角色。随着人们对血浆置换益处的认识不断提高，越来越多的患者和医疗保健提供者开始利用这种疗法，近年来，治疗性血浆置换市场规模显着扩张。

不同的应用和技术如何推动市场？

从技术角度来看，离心和薄膜过滤是最常用的方法，每种方法各有优点。离心系统广泛应用于神经系统疾病的治疗，而膜过滤较适用于肾臟疾病和某些血液系统疾病的治疗。其适应症涵盖从自体免疫疾病到血液系统疾病以及其他严重疾病。从最终用户来看，医院、专科诊所和捐血中心占据市场主导地位，越来越多的门诊病人机构采用TPE程序进行慢性疾病管理。越来越多的采用TPE的治疗方案正在扩大整体市场规模。

哪些创新正在塑造治疗性血浆置换的未来？

技术进步带来了更有效率、更安全、更方便的血浆置换系统，使医疗保健提供者更容易获得血浆置换。安全性更高的自动血浆分离机正日益成为医疗照护的标准，从而缩短了手术时间并改善了患者的预后。此外，TPE 系统整合的即时监控和数据分析功能使医疗保健提供者能够根据患者的具体情况量身定制治疗方案。此外，将 TPE 与免疫抑制疗法等其他治疗方法结合的趋势日益增长，这正在改变慢性病管理的面貌。

哪些因素推动了治疗性血浆置换市场的成长？

治疗性血浆置换市场的成长受到多种因素的推动，例如自体免疫疾病盛行率的上升、TPE 在神经系统疾病治疗中的应用日益广泛，以及新型血浆置换设备核准数量的不断增加。血浆分离设备的技术创新，加上医疗基础设施投资的不断增加，正在扩大 TPE 的应用范围。此外，医护人员越来越意识到在严重监护环境中使用 TPE 进行早期疗育的益处，这也推动了血浆置换的需求。符合 TPE 条件的患者群体不断扩大，尤其是在治疗罕见和复杂疾病方面，这进一步推动了市场的成长。最后，便携式且经济高效的血浆置换系统的开发，使这种救命疗法更加普及，预计将在未来几年推动市场发展。

部分

适应症（神经、肾臟、血液、代谢、其他）、最终用途（医院、专科诊所、门诊手术中心）

受访公司范例

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP15189

Global Therapeutic Plasma Exchange Market to Reach US$2.1 Billion by 2030

The global market for Therapeutic Plasma Exchange estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Neurological Disorders, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million by the end of the analysis period. Growth in the Renal Disorders segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$410.1 Million While China is Forecast to Grow at 5.7% CAGR

The Therapeutic Plasma Exchange market in the U.S. is estimated at US$410.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$331.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.5% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Therapeutic Plasma Exchange Market - Key Trends and Drivers Summarized

What Makes Therapeutic Plasma Exchange Critical in Modern Healthcare?

Therapeutic plasma exchange (TPE) has emerged as a life-saving procedure in treating various autoimmune diseases, hematological conditions, and neurological disorders. This procedure involves the removal of plasma from a patient's blood and its replacement with fresh plasma or a plasma substitute, which helps eliminate harmful antibodies and toxins. The increasing use of TPE in treating conditions such as Guillain-Barre syndrome, myasthenia gravis, and multiple sclerosis has underscored its critical role in healthcare. As awareness of the benefits of plasma exchange grows, more patients and healthcare providers are turning to this therapy, which has significantly expanded the therapeutic plasma exchange market in recent years.

How Are Different Applications and Technologies Driving the Market?

By technology, centrifugal-based and membrane filtration techniques are the most commonly employed methods, each offering distinct advantages. Centrifugal-based systems are widely used in treating neurological conditions, whereas membrane filtration is preferred for renal disorders and certain hematological diseases. Disease indication segments range from autoimmune disorders to blood dyscrasias and other critical illnesses. In terms of end-users, hospitals, specialty clinics, and blood donation centers dominate the market, with a growing number of outpatient facilities adopting TPE procedures for chronic disease management. The rising number of treatment options that incorporate TPE is expanding the market’s overall reach.

What Innovations Are Shaping the Future of Therapeutic Plasma Exchange?

Technological advancements have led to more efficient, safe, and user-friendly plasma exchange systems, making the procedure more accessible to healthcare providers. Automated apheresis devices, equipped with enhanced safety features, are increasingly becoming the standard of care, reducing procedure time and improving patient outcomes. Moreover, the integration of real-time monitoring and data analytics in TPE systems allows healthcare providers to customize treatments based on patient-specific conditions. Additionally, the growing trend of combining therapeutic plasma exchange with other treatment modalities, such as immunosuppressive therapies, is transforming the landscape of chronic disease management.

What Are the Key Drivers of Growth in the Therapeutic Plasma Exchange Market?

The growth in the therapeutic plasma exchange market is driven by several factors, including the rising prevalence of autoimmune diseases, the increased use of TPE in treating neurological conditions, and the growing number of regulatory approvals for novel plasma exchange devices. Technological innovations in apheresis devices, coupled with rising investments in healthcare infrastructure, are expanding the adoption of TPE. Additionally, increasing awareness among healthcare professionals about the benefits of early intervention with TPE in critical care settings is boosting the demand for plasma exchange. The expanding base of patients eligible for TPE, particularly in the treatment of rare and complex disorders, further propels market growth. Lastly, the development of portable and more cost-effective plasma exchange systems is expected to make this life-saving therapy more accessible, driving market expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Therapeutic Plasma Exchange market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Disease Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders, Other Disease Indications); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 47 Featured) -

  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Fenwal, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • HemaCare Corporation
  • Kawasumi Laboratories, Inc.
  • Terumo BCT, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Therapeutic Plasma Exchange - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Autoimmune Diseases Propels Growth of Therapeutic Plasma Exchange Market
    • Rising Demand for Non-invasive Therapeutic Solutions Strengthens Adoption of Plasma Exchange
    • Increasing Application of Therapeutic Plasma Exchange in Neurological Disorders Expands Market Opportunity
    • Advances in Medical Device Technologies Drive the Efficiency of Plasma Exchange Systems
    • Growing Use of Therapeutic Plasma Exchange in Pediatric Applications Spurs Market Growth
    • Rising Focus on Plasma-based Treatments for Critical Illnesses Drives Adoption of Therapeutic Plasma Exchange
    • Technological Innovations in Apheresis Systems Generate Demand for Advanced Plasma Exchange Solutions
    • Increased Awareness of Plasma Donation Programs Expands Adoption of Plasma Exchange Treatments
    • Growing Number of Plasma Collection Centers Propels the Therapeutic Plasma Exchange Market
    • Integration of AI and Data Analytics in Plasma Exchange Systems Strengthens Operational Efficiency
    • Surge in Clinical Trials Exploring Plasma Exchange for Emerging Therapies Boosts Market Demand
    • Increasing Use of Plasma Exchange in Immunology and Hematology Drives Market Expansion
    • Rising Prevalence of Infectious Diseases Spurs Demand for Plasma-based Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Therapeutic Plasma Exchange Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Therapeutic Plasma Exchange by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Therapeutic Plasma Exchange by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Renal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Renal Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Renal Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hematology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hematology Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hematology Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Metabolic Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Metabolic Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Therapeutic Plasma Exchange by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Therapeutic Plasma Exchange by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Therapeutic Plasma Exchange Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Therapeutic Plasma Exchange by Disease Indication - Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of World 15-Year Perspective for Therapeutic Plasma Exchange by Disease Indication - Percentage Breakdown of Value Sales for Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders and Other Disease Indications for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Therapeutic Plasma Exchange by End-Use - Hospitals, Specialty Clinics and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Therapeutic Plasma Exchange by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics and Ambulatory Surgery Centers for the Years 2015, 2025 & 2030

IV. COMPETITION